Tag: antibody
-
Antiverse secures $9.3M Series A for AI antibody platform
UK-based Antiverse, a biotech company developing AI-designed therapeutic antibodies for hard-to-target disease targets, has closed a $9.3 million Series A round led by Soulmates Ventures, with participation from Innovation Investment Capital, DOMiNO Ventures and existing investors DBW, Kadmos Capital and i&i Biotech Fund. The financing brings Antiverse’s total capital raised to more than $20 million. read more
Written by
-
Nuclera extends Series C funding to $87M to accelerate antibody engineering work
Biotech company Nuclera has secured an additional $12 million in financing, bringing its total Series C funding to $87 million. The extension was led by Elevage Medical Technologies and Jonathan Milner, with participation from existing investors British Business Bank and GK Goh. Nuclera is focused on streamlining protein expression and purification workflows through its benchtop read more
Written by
